Both in Pharmaceuticals
Edgewise Therapeutics vs Acadia Pharmaceuticals
Over the past year EWTX returned +116.6% and ACAD returned −1.7%; their daily moves had a correlation of 0.30.
EWTX +116.6% ACAD −1.7%Growth of $1, one year, split-adjusted
| Metric | EWTX | ACAD |
|---|---|---|
| Price | $37.53 | $21.47 |
| Market cap | $4.08B | $3.70B |
| Today | −0.40% | +4.38% |
| 1 month | −6.2% | +8.8% |
| 6 months | +1.5% | 0.0% |
| Year to date | +51.2% | −19.6% |
| 1 year | +108.8% | −4.0% |
| Revenue growth (YoY) | — | +16.4% |
| Gross margin | — | 90.8% |
| Net margin | — | 10.2% |
| P/E (TTM) | — | 9.7× |
| Price / sales | — | 3.2× |
| Net cash | $460.7M | $956.5M |
| Dividend yield | — | — |
| Volatility (60d) | 41.4% | 44.9% |
| Short % of float | 16.7% | 7.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).